bioMérieux revenue and financials
€81.05Change from previous close: +1.19%Absolute change: +€0.95
In the fiscal year ended December 2025, bioMérieux reported revenue of €4.07B (+2.26% year over year). Net income was €397.5M, a net margin of 9.8%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +2.26%
- 2025 vs 2024
- Net income growth
- −8.03%
- 2025 vs 2024
- Net margin
- 9.8%
- 2024: 10.9%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 5,575 | 5,770 | 5,259 | 5,187 | — |
| Current assets | 2,540 | 2,501 | 2,205 | 2,217 | — |
| Cash and equivalents | 570 | 450 | 352 | 553 | — |
| Inventory | 960 | 1,037 | 909 | 737 | — |
| Net property, plant and equipment | 1,657 | 1,696 | 1,506 | 1,370 | — |
| Goodwill | 728 | 730 | 699 | 813 | — |
| Other intangible assets | 402 | 492 | 529 | 625 | — |
| Long-term investments | 0.7 | 0.8 | 0.8 | 0.9 | — |
| Current liabilities | 1,065 | 1,134 | 1,088 | 1,131 | — |
| Accounts payable | 262 | 272 | 265 | 269 | — |
| Long-term debt | 211 | 207 | 234 | 225 | — |
| Total debt | 461 | 490 | 519 | 505 | — |
| Total liabilities | 1,469 | 1,559 | 1,507 | 1,544 | — |
| Total equity (incl. minority) | 4,106 | 4,211 | 3,752 | 3,643 | — |
| Retained earnings | 398 | 432 | 358 | 452 | — |
| Minority interest | 3.9 | 6.1 | 0.0 | 38.7 | — |